Transdermal patch: Rhône-Poulenc Rorer Inc. began U.S. Phase II and European Phase III trials of NOVN's transdermal patch, which releases estrogen and progestin

Noven Pharmaceuticals Inc. (NOVN), Miami Product: Transdermal patch Indication: Post-menopausal symptoms Status: Rhône-Poulenc Rorer Inc. began U.S. Phase II and European Phase III trials of NOVN's tr...